May 29, 2016 12:21 AM ET

Biotechnology

Company Overview of BELLUS Health Inc.

Executive Profile

Hélène F. Fortin FCPA auditor, FCA, ICD.D

Director and Chairman of Audit Committee, BELLUS Health Inc.
AgeTotal Calculated CompensationThis person is connected to 3 Board Members in 3 different organizations across 6 different industries.

See Board Relationships
58C$36,000

Background

Ms. Hélène F. Fortin, FCPA auditor, FCA, ICD.D serves as the Chairwoman of Loto-Québec Inc. Ms. Fortin served as the Chairwoman for Groupe Bikini Village Inc., since May 27, 2011 until June 21, 2013. She served as the Chairwoman at Canadian Broadcasting Corporation, Pension Plan. She served as a Director of Groupe Bikini Village Inc. since December 16, 2010 until June 21, 2013. She has been a Director of Loto-Québec Inc. since August 27, 2008. Ms. Fortin has been a Director ...

Corporate Headquarters

275 Armand-Frappier Boulevard
Laval, Quebec H7V 4A7

Canada

Phone: 450-680-4500
Fax: 450-680-4501

Board Members Memberships

2007-Present
Director
2008-Present
Director and Chairman of Audit Committee
2008-Present
Chairwoman, Chairman of Commercial Affairs Committee, Member of Audit Committee, Member of Human Resources Committee and Member of Governance & Ethics Committee

Education

Bachelor's Degree
Concordia University
Unknown/Other Education
McGill University

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

Total Value of OptionsC$81,000
Total Number of OptionsC$150,193

Total Compensation

Total Annual Cash CompensationC$36,000
Total Calculated CompensationC$36,000
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Ian C. Read Chairman, Chief Executive Officer and Chairman of Executive Committee
Pfizer Inc.
$1.9M
John C. Lechleiter Ph.D.Chairman, Chief Executive Officer and President
Eli Lilly and Company
$1.5M
Joseph Jimenez Jr., MBAChief Executive Officer
Novartis AG
$5.2M
Elliot Goldstein M.D.Chief Executive Officer, President and Director
ProMIS Neurosciences Inc.
--
Compensation as of Fiscal Year 2015.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact BELLUS Health Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.